Network origin in Ji-Hoon Park first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
TeraImmune, Inc.
 TeraImmune, Inc. BiotechnologyHealth Technology TeraImmune, Inc. engages in the development of customized cell therapies for autoimmune diseases using the patient’s own Treg cells. Its pipeline includes Hemophilia A, Multiple Sclerosis, and B cell lymphoma. The company was founded by Yong-Chan Kim and Ji-Hoon Park in 2016 and is headquartered in Gaithersburg, MD.
1
| Subsidiary | Biotechnology | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Ji-Hoon Park via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| BAUDAX BIO, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Chungnam National University | College/University | Doctorate Degree |
Statistics
International
| United States | 2 |
| South Korea | 2 |
Sectoral
| Health Technology | 2 |
| Consumer Services | 2 |
Operational
| Director/Board Member | 2 |
| Chief Executive Officer | 1 |
| Founder | 1 |
| Independent Dir/Board Member | 1 |
| Doctorate Degree | 1 |
Most connected contacts
| Insiders | |
|---|---|
| Yong-Chan Kim | 3 |
- Stock Market
- Insiders
- Ji-Hoon Park
- Company connections
